SII logo
SII logo

 

cyrus poonawala
Dr. Cyrus S. Poonawalla
Chairman and Managing Director
adar poonawala
Mr. Adar C. Poonawalla
CEO

NEWS & ANNOUNCEMENTS

  • Friday, March 13, 2026

    University of Oxford and Serum Institute of India Sign an Intellectual Property License Agreement to Advance ChAdOx1 NipahB Vaccine Candidate...Read more

  • Wednesday, March 11, 2026

    Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement...Read more

  • Tuesday, January 13, 2026

    Oxford University enters into licensing arrangement with SII to develop Rift Valley fever vaccine candidate...Read more

 

cyrus poonawala
Dr. Cyrus S. Poonawalla
Chairman and Managing Director
adar poonawala
Mr. Adar C. Poonawalla
CEO